LinkedInFrederiek Nederveen
Medior Consultant
Many organisations apply for the scheme they know and miss instruments that would fit better or apply alongside it. That is rarely carelessness. It is that nobody has sight of the whole landscape. Potential rarely goes unused because no suitable scheme exists. More often the full overview is missing: which instruments fit the project, which exclude each other, and in what order they should be applied for.
Public funding is fragmented by design. It sits across European, national and regional levels, split between grants, subsidies, tax incentives and financing instruments, each with its own rules, deadlines and definitions. Few finance teams have the time to track all of it, so most companies claim the one or two instruments they already know and leave the rest unclaimed.
The cost of that is rarely visible, because you do not see the capital you did not apply for. It shows up instead as growth financed with more expensive money than it needed, as innovation costs carried entirely by the operating budget, and as margins under more pressure than they should be.
There is a second problem beneath the first. Funding that is claimed opportunistically tends to arrive unpredictably, which makes it almost useless for liquidity planning, and some of it fails to hold up when an authority looks closely. For a finance team, an unverified claim is a liability on the balance sheet rather than a gain.
It is why most finance leaders end up asking the same three questions: is the effort worth it, what is the risk of rejection, and when will the money actually arrive. The goal is not simply more funding. It is more funding that is forecastable, that improves cash flow and margins, and that survives scrutiny.
A funding mix does not mean stacking several schemes onto the same project. It usually arises across the whole roadmap: different projects, different phases, different instruments.
The risk arises mainly after the award: through unmet conditions, project changes, ineligible costs, missing evidence or missed deadlines. In a combined mix the documentation therefore has to be cleanly separated from the outset.
Treating public funding as a coordinated mix rather than a set of one-off applications changes the numbers in four ways.
A full review across grants, subsidies, tax incentives and financing usually finds levers the finance team did not know applied. That is capital already earned through the work you are doing.
Most of this funding is non-dilutive, and much of it does not have to be repaid, so every euro of it is cheaper than the equity or debt it replaces. Planned well, it lowers the blended cost of financing your growth and supports the equity ratio.
Tax-based instruments return value against costs you have already carried, which turns innovation from a pure cost line into a systematically refinanced one. That improves cash flow and takes pressure off short-term margins.
Mapped across a multi-year horizon and synchronised with your reporting and tax filing, public funding becomes a predictable line in the plan rather than an occasional windfall, with a time to cash you can actually plan around. That is what makes it useful to a finance team in the first place.
Done properly, this turns public funding from a set of lucky wins into a managed part of the capital structure: a controllable, audit-secure financing component, integrated into your finance, governance and tax processes.
Which instruments are open to you depends on three factors. Together they decide what is available at all.
Size determines access. Many schemes are open only to SMEs, others are size-independent, and some carry a higher funding rate for smaller companies.
Young companies and start-ups. Often without meaningful tax liability or a long history. Instruments that work independently of profit or creditworthiness matter most here. Note that tax-based instruments generally require employees on the payroll.
SMEs. The widest choice. Here the question is rarely whether funding exists, but through which instrument and with what delimitation.
Larger companies. Fewer schemes are open, but the volumes are larger. Delimiting the eligible share becomes more important.
Feasibility, development, demonstration, investment and market entry each follow their own funding logic. A project that is too early for one instrument can be exactly right for another.
The sector sets the emphasis. In most sectors development funding carries the largest share, complemented by investment and environmental schemes. The location additionally decides which regional schemes are open.
A well-built mix draws on four kinds of instrument, each doing a different job.
Non-repayable funding for specific projects, from Horizon Europe and the EU Innovation Fund at European level through to national and regional innovation and investment grants such as ZIM in Germany or MIT R&D in the Netherlands.
Ongoing support that carries the operating economics rather than the investment, such as carbon contracts for difference in Germany, which cover the additional running cost of low-carbon production.
Value returned through the tax system rather than through an application round, including the R&D instruments WBSO in the Netherlands and Forschungszulage in Germany, the Innovatiebox for profit linked to innovation, and investment incentives such as EIA and MIA/Vamil in the Netherlands. These are the dependable layer, because they follow spending you are already committed to.
Favourable loans and facilities, such as KfW financing in Germany, which sit alongside grants and subsidies to complete the capital stack.
The value is not in any single instrument. It is in combining them correctly across the portfolio, so the mix returns more than the sum of its parts without breaching the rules that govern how they stack.
We assess the whole landscape rather than one scheme, and we do it before the project starts. We also look at what has already been carried out and whether anything is still possible there.
The value sits in knowing which instruments exist, which ones you qualify for and how the rules interact when they are combined, and that judgement is made by people who know the programmes and the regulations. Technology runs in the background to widen the search, support the analysis and take over the repetitive administrative work. It does not decide what is eligible or how instruments combine. The human factor is the one that carries the result.
Completed, running and planned projects are recorded and ordered by phase.
Each project is matched to the right instrument at regional, national and European level.
Deadlines, submission windows and dependencies decide what is applied for first.
The same costs may not be funded twice. That delimitation is built into the application, not into the accounting.
We then make the mix forecastable. The sequence is synchronised with your financial close and your tax filing and translated into figures your finance team can plan around, so public funding becomes a line you can rely on with a controlled time to cash rather than a random arrival. We also set clear roles across finance, tax and the technical teams, so the process does not depend on one person and scales across business units.
And we protect what is claimed, with a defensible eligibility classification and clean documentation from the start. This runs as a standing corporate standard rather than a one-off application, which is what keeps it repeatable and low-risk year after year.
Your competitors use these funding levers to lower their cost of capital, and the same levers are open to you. The difference is rarely about eligibility. It comes down to who runs funding as a managed process and who claims only what is familiar.
So the question is not whether the potential exists in your organisation. It is how much of it you are already using, and what it costs you not to.